Amgen’s T cell engager notches new major lung cancer victorynews2026-09-08T17:53:52+00:00September 8th, 2026|Endpoints News|
Sanofi spells out asthma data, AstraZeneca details COPD win at #ERS26news2026-09-08T16:24:59+00:00September 8th, 2026|Endpoints News|
Expanding its biopharma plans, Anthropic looks for a life-sciences dealmakernews2026-09-08T15:56:33+00:00September 8th, 2026|Endpoints News|
Krazati withdrawal completed; Wegovy trial meets endpoint for kids ages 6 to 12news2026-09-08T15:21:33+00:00September 8th, 2026|Endpoints News|
Sandoz unveils plan for biosimilar expansion and new $300M factory in Slovenia news2026-09-08T14:14:32+00:00September 8th, 2026|Endpoints News|
Bristol Myers claims Phase 2 success for GPRC5D-directed CAR-Tnews2026-09-08T14:08:51+00:00September 8th, 2026|Endpoints News|
Why consumer apps set their sights on patient health recordsnews2026-09-08T13:00:00+00:00September 8th, 2026|Endpoints News|
Moonwalk raises $70M to test siRNA treatment for obesitynews2026-09-08T12:00:17+00:00September 8th, 2026|Endpoints News|
Inhibrx targets OX40 agonist-cancer vaccine studies from early next yearnews2026-09-08T11:30:32+00:00September 8th, 2026|Endpoints News|